0001144204-19-018267.txt : 20190405 0001144204-19-018267.hdr.sgml : 20190405 20190405060709 ACCESSION NUMBER: 0001144204-19-018267 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20190405 FILED AS OF DATE: 20190405 DATE AS OF CHANGE: 20190405 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PRANA BIOTECHNOLOGY LTD CENTRAL INDEX KEY: 0001131343 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-49843 FILM NUMBER: 19733426 BUSINESS ADDRESS: STREET 1: P.O. BOX 655 CITY: CARLTON, SOUTH VIC STATE: C3 ZIP: 3053 BUSINESS PHONE: 61-0-9824-5254 MAIL ADDRESS: STREET 1: P.O. BOX 655 CITY: CARLTON, SOUTH VIC STATE: C3 ZIP: 3053 6-K 1 tv518273_6k.htm 6-K

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

  

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR

15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of April 2019

 

Prana Biotechnology Limited

(Name of Registrant)

 

Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia

(Address of Principal Executive Office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F x                   Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes ¨                      No x 

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____

 

This Form 6-K is being incorporated by reference into the Registrant’s Registration Statements on Form F-3 (File No. 333-220886) and Form S-8 (File No. 333-228671).

 

 

 

 

 

PRANA BIOTECHNOLOGY LIMITED

 

6-K Items

 

1.

Results of Meeting

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  

  PRANA BIOTECHNOLOGY LIMITED
    (Registrant)
     
     
  By: /s/ Geoffrey Kempler  
    Geoffrey Kempler,
    Executive Chairman

  

April 5, 2019

 

 

 

 

 

 

 

COMPANY ANNOUNCEMENT

(ASX: PBT)

 

RESULTS OF GENERAL MEETING

 

 

Friday, 5th April 2019

 

The Company wishes to advise that all resolutions contained in the Notice of Meeting were carried on a show of hands.

 

In accordance with ASX Listing rule 3.13.2 and Section 251AA(1) of the Corporations Act 2001, the following page provides information in relation to the proxy votes received for each resolution considered by Members of the Company at the General Meeting held today at 11:00 a.m. (AEDT).

 

The Chairman voted undirected proxies in his control in favour of all resolutions.

 

Resolution 5 is a special resolution and required 75% approval to be passed. This threshold has been achieved and the resolution passed.

 

The Company will make further announcements when shares and warrants are issued to Life Biosciences and under the placement, and the change of the Company’s name approved at today’s meeting is completed. The elections of Dr Sinclair and Mr Edwards will also take effect at closing of the issue of shares and warrants to Life Biosciences.

 

On behalf of the Board

  

 

Phillip Hains

Company Secretary

Prana Biotechnology Limited

 

 

 

Level 3, 62 Lygon Street, Carlton

Victoria Australia 3053

 

 

Page 1 of 1

 

Telephone: 61 3 9824 5254

Facsimile: 61 3 9822 7735

 

 

 

¨ Show direct votes?

 

Prana Biotechnology Limited

General Meeting

Friday, 05 April 2019

Voting Results

 

The following information is provided in accordance with section 251AA(2) of the Corporations Act 2001 (Cth).

 

Resolution details   Instructions given to validly appointed proxies
(as at proxy close)
  Number of votes cast on the poll
(where applicable)
  Resolution Result
Resolution Resolution Type   For Against Proxy's
Discretion
Abstain   For Against Abstain*   Carried /
Not Carried
1 Approval of transaction with Life Biosciences LLC Ordinary   81,601,403 10,093,268 2,614,310 585,348   Carried on a show of hands   Carried
             
2 Approval of the Company acquiring a relevant interest in its own shares Ordinary   58,302,214 10,361,628 2,654,310 23,576,177   Carried on a show of hands   Carried
             
3 Election of Dr David Sinclair as a Director Ordinary   79,303,094 10,309,755 2,614,310 2,667,170   Carried on a show of hands   Carried
             
4 Election of Mr Tristan Edwards as a Director Ordinary   79,139,634 10,358,815 2,614,310 2,781,570   Carried on a show of hands   Carried
             
5 Change of name Special   75,754,713 12,463,395 2,614,310 4,061,911   Carried on a show of hands   Carried
             
6 Ratification of prior issue of shares Ordinary   39,356,981 11,842,887 2,619,310 2,784,851   Carried on a show of hands   Carried
             
7 Approval of issue of shares and warrants Ordinary   77,115,081 12,295,547 2,641,110 2,842,591   Carried on a show of hands   Carried
             

 

 * Votes cast by a person who abstains on an item are not counted in calculating the required majority on a poll.

 

 

GRAPHIC 2 image_001.jpg GRAPHIC begin 644 image_001.jpg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

Z'_ KN(Y8Y5W1NKKZJ;SH1Y)+F73NCEQ& C5DY1=F>GLZ1J69@JCDDG %GN*[FBN3%X.GBH\L]^C.C#XF="5X_<>8W,+VUFJG[ MS!5R7$ M1=J=FON/5IYE2:]_1G#!5W8)R?:FESCC@>U=M'X&MU<%[V9@.P4"M2R\,Z79 M,'6W\QQT:4[OTZ4Z>3XB3]ZR^?\ D.>8T4O=NSC]&T"\U,A\-#;Y!,K#K_NC MO7H%I:16<"PPKM0?F3ZFIP .E%>YA,!2PRO'63ZGE8C%3KO71=@HHHKM.8** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9 end GRAPHIC 3 image_002.jpg GRAPHIC begin 644 image_002.jpg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end